OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuroimmunology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation	91
A systematic review of cases of CNS demyelination following COVID-19 vaccination	86
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19	75
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception	70
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases	69
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients	66
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study	65
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms	57
Inflammation in Huntington's disease: A few new twists on an old tale	54
The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications	52
Stellate ganglion block reduces symptoms of Long COVID: A case series	47
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature	43
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation	40
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?	39
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease	39
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure	39
Toll-like receptors in Alzheimer's disease	37
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement	37
Stiff person syndrome spectrum disorders; more than meets the eye	35
Multipotential and systemic effects of traumatic brain injury	34
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment	33
Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis	33
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature	33
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease	32
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine	32

LncRNA NEAT1/miR-128-3p/AQP4 axis regulating spinal cord injury-induced neuropathic pain progression	31
A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection	30
Anti-MAG neuropathy: From biology to clinical management	29
Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review	29
Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retr	29
Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?	29
The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases	29
Probiotics protect against gut dysbiosis associated decline in learning and memory	29